FDA Inspection
CSL Behring L.L.C.CSL Behring L.L.C. – FDA Inspection, Mar 2, 2023
Record Details
This FDA Inspection record concerns CSL Behring L.L.C., with an inspection on March 2, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ef49327a-c2e6-486f-be49-cd85f5b500f8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1202268
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of CSL Behring L.L.C.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| June 25, 2026 | Not classified | Chicago District Office | |
| September 24, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 23, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| October 18, 2018 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 19, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for CSL Behring L.L.C.
- FDA Inspection 1284730 - 2026-06-25
- FDA Inspection 1153026 - 2021-09-24
- FDA Inspection 1090775 - 2019-05-23
- FDA Inspection 1072948 - 2018-10-18
- FDA Inspection 1019044 - 2017-07-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.